Clinical Research, Pharma & Healthcare FinancingCytovation Appoints Martin Dewhurst to its Board of DirectorsGlobeNewswireFebruary 13, 2025February 14, 2025 by GlobeNewswireFebruary 13, 2025February 14, 2025079 Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces the appointment of Mr. Martin Dewhurst to...
